STOCK TITAN

[Form 4] FIREFLY NEUROSCIENCE, INC. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Firefly Neuroscience (AIFF): insider group reports open-market sales

A group of reporting persons led by Windsor Private Capital LP, identified as more than 10% beneficial owners, disclosed multiple sales of Firefly Neuroscience common stock under Rule 144. Reported transactions include sales on 10/09/2025 (30,126 shares at $2.9441), 10/10/2025 (74,810 shares at $2.6994), 10/13/2025 (32,136 shares at $2.6525), and 10/14/2025 (29,500 shares at $2.739). Following these trades, the group reports 1,470,201 shares beneficially owned indirectly.

The securities are held by Windsor; related entities and individuals (including WPC entities and certain officers) may be deemed beneficial owners, with stated disclaimers of beneficial ownership except to the extent of pecuniary interest.

Firefly Neuroscience (AIFF): insider group reports open-market sales

Un gruppo di persone che riportano incidenti guidato da Windsor Private Capital LP, identificato come titolare beneficiario oltre il 10%, ha reso note multiple vendite di azioni ordinarie di Firefly Neuroscience ai sensi della Regola 144. Le transazioni riportate includono vendite il 10/09/2025 (30.126 azioni a 2,9441 USD), il 10/10/2025 (74.810 azioni a 2,6994 USD), il 13/10/2025 (32.136 azioni a 2,6525 USD) e il 14/10/2025 (29.500 azioni a 2,739 USD). Dopo queste operazioni, il gruppo riferisce di possedere 1.470.201 azioni in modo indiretto.

I titoli sono detenuti da Windsor; entità e individui correlati (incluse le entità WPC e alcuni funzionari) possono essere considerati proprietari beneficiari, con specifiche esclusioni di proprietà beneficiaria ad eccezione della misura dell’interesse pecuniario.

Firefly Neuroscience (AIFF): grupo de insiders reporta ventas en el mercado abierto

Un grupo de personas informantes liderado por Windsor Private Capital LP, identificado como titulares beneficiarios de más del 10%, informó múltiples ventas de acciones ordinarias de Firefly Neuroscience bajo la Regla 144. Las transacciones reportadas incluyen ventas el 10/09/2025 (30.126 acciones a 2,9441 USD), el 10/10/2025 (74.810 acciones a 2,6994 USD), el 13/10/2025 (32.136 acciones a 2,6525 USD) y el 14/10/2025 (29.500 acciones a 2,739 USD). Tras estas operaciones, el grupo reporta 1.470.201 acciones poseídas de forma indirecta.

Los valores los mantiene Windsor; entidades y personas relacionadas (incluidas las entidades WPC y ciertos directivos) pueden ser considerados titulares de beneficios, con declaraciones de exención de titularidad de beneficios salvo el alcance de interés pecuniario.

Firefly Neuroscience (AIFF): 내부자 그룹이 공개시장 매도 보고

Windsor Private Capital LP가 이끄는 보고 당사자 그룹은 10%를 초과하는 유익한 소유자로 식별되었으며, Rule 144에 따라 Firefly Neuroscience의 보통주 다수의 매도를 공시했습니다. 보고된 거래에는 2025년 10월 9일(30,126주, 2.9441달러), 2025년 10월 10일(74,810주, 2.6994달러), 2025년 10월 13일(32,136주, 2.6525달러) 및 2025년 10월 14일(29,500주, 2.739달러)이 포함됩니다. 이러한 거래 후 그룹은 1,470,201주간접적으로 보유한다고 보고합니다.

이 증권은 Windsor가 보유하고 있으며, 관련 기관 및 개인(WPC 기관 및 특정 이사 포함)은 유익한 소유자로 간주될 수 있고, 이익 소유권에 대한 면책 선언은 재정적 이해관계의 범위를 벗어날 때에만 적용됩니다.

Firefly Neuroscience (AIFF) : groupe d'informateurs rapporte des ventes sur le marché libre

Un groupe de personnes signalantes dirigé par Windsor Private Capital LP, identifié comme détenant plus de 10% des actions bénéficiaires, a divulgué plusieurs ventes d'actions ordinaires de Firefly Neuroscience conformément à la Règle 144. Les transactions rapportées comprennent des ventes le 09/10/2025 (30 126 actions à 2,9441 USD), le 10/10/2025 (74 810 actions à 2,6994 USD), le 13/10/2025 (32 136 actions à 2,6525 USD) et le 14/10/2025 (29 500 actions à 2,739 USD). Suite à ces transactions, le groupe déclare posséder 1 470 201 actions de manière indirecte.

Les titres sont détenus par Windsor; les entités associées et les individus (y compris les entités WPC et certains dirigeants) peuvent être considérés comme bénéficiaires, avec des déclarations d’exemption de propriété bénéficiaire, sauf dans la mesure de tout intérêt pécuniaire.

Firefly Neuroscience (AIFF): Insidergruppe meldet Verkäufe am freien Markt

Eine Gruppe meldender Personen unter Leitung von Windsor Private Capital LP, identifiziert als mehr als 10% begünstigte Eigentümer, hat mehrere Verkäufe von Firefly Neuroscience Stammaktien gemäß Regel 144 offengelegt. Zu den gemeldeten Transaktionen gehören Verkäufe am 09.10.2025 (30.126 Aktien zu 2,9441 USD), am 10.10.2025 (74.810 Aktien zu 2,6994 USD), am 13.10.2025 (32.136 Aktien zu 2,6525 USD) und am 14.10.2025 (29.500 Aktien zu 2,739 USD). Nach diesen Geschäften meldet die Gruppe 1.470.201 Aktien als direkt begünstigt.

Die Wertpapiere werden von Windsor gehalten; verwandte Einheiten und Einzelpersonen (einschließlich WPC-Einheiten und bestimmter Führungskräfte) können als begünstigte Eigentümer angesehen werden, mit ausdrücklichen Vermerken des Eigentumsausschlusses, außer im Umfang eines finanziellen Interesses.

Firefly Neuroscience (AIFF): جماعة من المبلغين عن insider تقارير مبيعات في السوق المفتوح

أفاد جماعة من الأشخاص المبلغين بقيادة Windsor Private Capital LP، المعروفين كمالكين مستفيدين يتجاوزون 10%، بوجود عدة مبيعات لأسهم Firefly Neuroscience العادية وفق قاعدة 144. تشمل المعاملات المبلغ عنها البيع في 09/10/2025 (30,126 سهماً بسعر 2.9441 دولار)، وفي 10/10/2025 (74,810 سهماً بسعر 2.6994 دولار)، وفي 13/10/2025 (32,136 سهماً بسعر 2.6525 دولار)، وفي 14/10/2025 (29,500 سهماً بسعر 2.739 دولار). عقب هذه الصفقات، ذكرت المجموعة أنها تملك 1,470,201 سهم منافعياً بشكل غير مباشر.

تُحتفظ الأوراق المالية بويندور Windsor؛ قد يُنظر إلى كيانات وأفراد ذوي صلة (بما في ذلك كيانات WPC وبعض المديرين) كمالكين مستفيدين، مع إعلانات استثناء من الملكية المستفيدة باستثناء مدى المصالح المالية.

Firefly Neuroscience (AIFF): 内部人士小组报告公开市场交易

由 Windsor Private Capital LP 领导、被识别为超过 10% 实益拥有者的一组信息披露人员披露了 Firefly Neuroscience 普通股在 Rule 144 下的多笔出售。已报道的交易包括 2025-10-09 的出售(30,126 股,价格 2.9441 美元)、2025-10-10 的出售(74,810 股,2.6994 美元)、2025-10-13 的出售(32,136 股,2.6525 美元)以及 2025-10-14 的出售(29,500 股,2.739 美元)。在这些交易之后,该组报告实现了 1,470,201 股间接持有。

证券由 Windsor 持有;相关实体与个人(包括 WPC 实体及某些高级职员)可能被视为受益所有人,声明对受益所有权的免责声明仅在经济利益范围内有效。

Positive
  • None.
Negative
  • None.

Firefly Neuroscience (AIFF): insider group reports open-market sales

Un gruppo di persone che riportano incidenti guidato da Windsor Private Capital LP, identificato come titolare beneficiario oltre il 10%, ha reso note multiple vendite di azioni ordinarie di Firefly Neuroscience ai sensi della Regola 144. Le transazioni riportate includono vendite il 10/09/2025 (30.126 azioni a 2,9441 USD), il 10/10/2025 (74.810 azioni a 2,6994 USD), il 13/10/2025 (32.136 azioni a 2,6525 USD) e il 14/10/2025 (29.500 azioni a 2,739 USD). Dopo queste operazioni, il gruppo riferisce di possedere 1.470.201 azioni in modo indiretto.

I titoli sono detenuti da Windsor; entità e individui correlati (incluse le entità WPC e alcuni funzionari) possono essere considerati proprietari beneficiari, con specifiche esclusioni di proprietà beneficiaria ad eccezione della misura dell’interesse pecuniario.

Firefly Neuroscience (AIFF): grupo de insiders reporta ventas en el mercado abierto

Un grupo de personas informantes liderado por Windsor Private Capital LP, identificado como titulares beneficiarios de más del 10%, informó múltiples ventas de acciones ordinarias de Firefly Neuroscience bajo la Regla 144. Las transacciones reportadas incluyen ventas el 10/09/2025 (30.126 acciones a 2,9441 USD), el 10/10/2025 (74.810 acciones a 2,6994 USD), el 13/10/2025 (32.136 acciones a 2,6525 USD) y el 14/10/2025 (29.500 acciones a 2,739 USD). Tras estas operaciones, el grupo reporta 1.470.201 acciones poseídas de forma indirecta.

Los valores los mantiene Windsor; entidades y personas relacionadas (incluidas las entidades WPC y ciertos directivos) pueden ser considerados titulares de beneficios, con declaraciones de exención de titularidad de beneficios salvo el alcance de interés pecuniario.

Firefly Neuroscience (AIFF): 내부자 그룹이 공개시장 매도 보고

Windsor Private Capital LP가 이끄는 보고 당사자 그룹은 10%를 초과하는 유익한 소유자로 식별되었으며, Rule 144에 따라 Firefly Neuroscience의 보통주 다수의 매도를 공시했습니다. 보고된 거래에는 2025년 10월 9일(30,126주, 2.9441달러), 2025년 10월 10일(74,810주, 2.6994달러), 2025년 10월 13일(32,136주, 2.6525달러) 및 2025년 10월 14일(29,500주, 2.739달러)이 포함됩니다. 이러한 거래 후 그룹은 1,470,201주간접적으로 보유한다고 보고합니다.

이 증권은 Windsor가 보유하고 있으며, 관련 기관 및 개인(WPC 기관 및 특정 이사 포함)은 유익한 소유자로 간주될 수 있고, 이익 소유권에 대한 면책 선언은 재정적 이해관계의 범위를 벗어날 때에만 적용됩니다.

Firefly Neuroscience (AIFF) : groupe d'informateurs rapporte des ventes sur le marché libre

Un groupe de personnes signalantes dirigé par Windsor Private Capital LP, identifié comme détenant plus de 10% des actions bénéficiaires, a divulgué plusieurs ventes d'actions ordinaires de Firefly Neuroscience conformément à la Règle 144. Les transactions rapportées comprennent des ventes le 09/10/2025 (30 126 actions à 2,9441 USD), le 10/10/2025 (74 810 actions à 2,6994 USD), le 13/10/2025 (32 136 actions à 2,6525 USD) et le 14/10/2025 (29 500 actions à 2,739 USD). Suite à ces transactions, le groupe déclare posséder 1 470 201 actions de manière indirecte.

Les titres sont détenus par Windsor; les entités associées et les individus (y compris les entités WPC et certains dirigeants) peuvent être considérés comme bénéficiaires, avec des déclarations d’exemption de propriété bénéficiaire, sauf dans la mesure de tout intérêt pécuniaire.

Firefly Neuroscience (AIFF): Insidergruppe meldet Verkäufe am freien Markt

Eine Gruppe meldender Personen unter Leitung von Windsor Private Capital LP, identifiziert als mehr als 10% begünstigte Eigentümer, hat mehrere Verkäufe von Firefly Neuroscience Stammaktien gemäß Regel 144 offengelegt. Zu den gemeldeten Transaktionen gehören Verkäufe am 09.10.2025 (30.126 Aktien zu 2,9441 USD), am 10.10.2025 (74.810 Aktien zu 2,6994 USD), am 13.10.2025 (32.136 Aktien zu 2,6525 USD) und am 14.10.2025 (29.500 Aktien zu 2,739 USD). Nach diesen Geschäften meldet die Gruppe 1.470.201 Aktien als direkt begünstigt.

Die Wertpapiere werden von Windsor gehalten; verwandte Einheiten und Einzelpersonen (einschließlich WPC-Einheiten und bestimmter Führungskräfte) können als begünstigte Eigentümer angesehen werden, mit ausdrücklichen Vermerken des Eigentumsausschlusses, außer im Umfang eines finanziellen Interesses.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Windsor Private Capital LP

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
FIREFLY NEUROSCIENCE, INC. [ AIFF ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/09/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 10/09/2025 S(2) 30,126 D $2.9441 1,606,647 I See footnote(3)
Common Stock(1) 10/10/2025 S(2) 74,810 D $2.6994 1,531,837 I See footnote(3)
Common Stock(1) 10/13/2025 S(2) 32,136 D $2.6525 1,499,701 I See footnote(3)
Common Stock(1) 10/14/2025 S(2) 29,500 D $2.739 1,470,201 I See footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
Windsor Private Capital LP

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
WPC Management Services Inc.

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
WPC GP I Inc.

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Kupinsky Jordan

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HJRK Holdings Inc.

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
HJR Kupinsky 2013 Family Trust

(Last) (First) (Middle)
395 BROOKE AVENUE

(Street)
TORONTO A6 M5M 2L5

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Marcello Rocco

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
Cundari John

(Last) (First) (Middle)
22 ST. CLAIR AVENUE EAST
SUITE 202

(Street)
TORONTO A6 M4T 2S3

(City) (State) (Zip)

Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. This Form 4 is filed jointly by Windsor Private Capital LP ("Windsor"), WPC Management Services Inc. ("WPC Management Services"), WPC GP I Inc. ("WPC"), Jordan Kupinsky ("Mr. Kupinsky"), HJRK Holdings Inc. ("HJRK"), HJR Kupinsky 2013 Family Trust ("HJRK Trust"), Rocco Marcello ("Mr. Marcello") and John Cundari ("Mr. Cundari", and collectively, the "Reporting Persons"). The Reporting Persons are members of a "group" that beneficially owns more than 10% of the shares of common stock of Firefly Neurosciences, Inc. (the "Issuer").
2. These transactions occurred pursuant to broker-dealer sales conducted in accordance with Rule 144 under the Securities Act of 1933, as amended.
3. The reported securities are held directly by Windsor. Mr. Marcello is Founder, Chairman and Chief Executive Officer of Windsor. Mr. Cundari is President of Windsor. Mr. Kupinsky is Managing Partner of Windsor. WPC is the general partner of Windsor and WPC Management Services is the sole shareholder of WPC. Mr. Marcello, Mr. Cundari and Mr. Kupinsky are the directors of WPC and WPC Management Services. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari may be deemed to beneficially own the reported securities. WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello and Mr. Cundari disclaim beneficial ownership of the securities held directly by Windsor except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of WPC Management Services, WPC, Mr. Kupinsky, Mr. Marcello or Mr. Cundari is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
Windsor Private Capital LP, by its General Partner, WPC GP I Inc., /s/ John Cundari, Partner 10/14/2025
WPC Management Services Inc., /s/ John Cundari, Partner 10/14/2025
WPC GP I Inc., /s/ John Cundari, Partner 10/14/2025
/s/ Jordan Kupinsky 10/14/2025
HJRK Holdings Inc., /s/ Jordan Kupinsky, President and Director 10/14/2025
HJR Kupinsky 2013 Family Trust, by its Trustee, Jordan Kupinsky, /s/ Jordan Kupinsky 10/14/2025
/s/ Rocco Marcello 10/14/2025
/s/ John Cundari 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did AIFF insiders report in this Form 4?

A group including Windsor Private Capital LP reported open-market sales of common stock under Rule 144 across four dates in October 2025.

How many AIFF shares were sold and at what prices?

Reported sales were 30,126 at $2.9441 on 10/09, 74,810 at $2.6994 on 10/10, 32,136 at $2.6525 on 10/13, and 29,500 at $2.739 on 10/14.

How many AIFF shares remain beneficially owned after these trades?

The filing lists 1,470,201 shares beneficially owned following the reported transactions, held indirectly.

Who are the reporting persons for AIFF in this filing?

The group includes Windsor Private Capital LP, WPC Management Services Inc., WPC GP I Inc., Jordan Kupinsky, HJRK Holdings Inc., HJR Kupinsky 2013 Family Trust, Rocco Marcello, and John Cundari.

How is ownership of the reported AIFF shares structured?

The shares are held by Windsor. Certain related entities and individuals may be deemed beneficial owners, with disclaimers except for pecuniary interest.

What method was used to sell the AIFF shares?

The sales were broker-dealer transactions conducted in accordance with Rule 144 under the Securities Act of 1933.
Firefly Neuroscience Inc.

NASDAQ:AIFF

AIFF Rankings

AIFF Latest News

AIFF Latest SEC Filings

AIFF Stock Data

36.85M
8.71M
38.52%
10.85%
13.28%
Software - Application
Services-prepackaged Software
Link
United States
KENMORE